Company / Profit Margin
Biogen Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
13.1%
FY2025
5-year range
11.8% / 29.9%
FY2021-FY2025
Trend
-22.5%
vs FY2024
Sector context
#34 of 143
Health Care
What the data says
Biogen's profit margin of 13.1% is higher than 76% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from 11.8% in FY2023 to 41.0% in FY2019.
Based on SEC 10-K filings.
13.1% in FY2025 with a 5-year CAGR of -16.7%. Top quartile in the Health Care sector.
Improved from 11.8% to 13.1% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -16.9pp
- 5-Year Change
- -16.7pp
- 10-Year Change
- -
Sector benchmark
Top 24% in Health CareTop 24% of 143This company 13.1% Sector average -899.4%
▼
+101.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 22.5% year-over-year.
- Currently 912.5pp above the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.1% | -22.5% |
| FY2024 | 16.9% | +42.8% |
| FY2023 | 11.8% | -60.6% |
| FY2022 | 29.9% | +111.4% |
| FY2021 | 14.2% | -52.4% |
| FY2020 | 29.8% | -27.3% |
| FY2019 | 41.0% | +24.4% |
| FY2018 | 32.9% | +59.2% |
| FY2017 | 20.7% | -36.0% |
| FY2016 | 32.3% | -1.9% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026